In the BioHarmony Drug Report Database
Clorotekal, Nesacaine, Nesacaine-mpf (chloroprocaine) is a small molecule pharmaceutical. Chloroprocaine was first approved as Clorotekal on 1982-01-01. It is used to treat pain in the USA. It is known to target ryanodine receptor 1 and ryanodine receptor 2. Chloroprocaine hydrochloride’s patents are valid until 2033-12-11 (FDA).
Image (chem structure or protein)